Price to sales forward of Concentra Group Holdings Parent, Inc. – NYSE:CON
The article focuses on the "Price to sales forward" metric for Concentra Group Holdings Parent, Inc. (NYSE: CON) within the TradingView platform. It briefly mentions the company's market status and provides navigation to financial data, news, and other related information on the platform. The content primarily serves as a placeholder for financial data that would be displayed on TradingView.
Enterprise value to EBIT forward of Concentra Group Holdings Parent, Inc. – NYSE:CON
This article provides financial information for Concentra Group Holdings Parent, Inc. (NYSE: CON), specifically focusing on its enterprise value to EBIT forward. It is presented in a data-centric format from TradingView, including market data provided by ICE Data Services and FactSet.
Enterprise value to revenue forward of Concentra Group Holdings Parent, Inc. – NYSE:CON
This article provides financial information for Concentra Group Holdings Parent, Inc. (NYSE: CON), specifically focusing on its enterprise value to revenue forward metric. It highlights the stock's status as market closed with no trades, linking to various financial and analytical tools available on TradingView for further research. The content appears to be a stub or a section of a larger financial data page.
CON - Concentra Group Holdings Parent Inc Latest SEC Filings
This article provides the latest SEC filings and comprehensive financial data for Concentra Group Holdings Parent Inc (CON). It covers various financial metrics, stock performance indicators, insider and institutional ownership, and analyst recommendations, offering a detailed snapshot of the company's current market position.
CON - Concentra Group Holdings Parent Inc Options
This article provides comprehensive financial data for Concentra Group Holdings Parent Inc (CON), including its last close price, market capitalization, income, sales, and various financial ratios. It also details dividend information, IPO date, EPS, sales growth, insider and institutional ownership, profitability margins, and stock performance data. The data indicates strong recent performance and growth metrics for the company.
Concentra Group Holdings stock hits all-time high at 31.45 USD
Concentra Group Holdings Parent Inc. stock has reached an all-time high of $31.45 USD, reflecting a 51.85% increase over the past year and a 57% year-to-date return. Despite being considered overvalued by InvestingPro, the company boasts a perfect Piotroski Score of 9, indicating strong financial health. Analysts from Truist Securities, Mizuho, Goldman Sachs, and William Blair have raised price targets or initiated coverage with positive ratings following strong first-quarter results and the opening of a new medical center.
CON - Concentra Group Holdings Parent Inc Short Interest
This article provides a detailed financial overview of Concentra Group Holdings Parent Inc (CON), including its short interest, key financial metrics, performance indicators, and analyst recommendations. It highlights the company's recent stock performance, insider and institutional ownership, and profitability margins, presenting a comprehensive snapshot for potential investors.
Why Concentra (CON) Is Up 5.6% After Russell Shift And New Clinic Opening – And What's Next
Concentra Group Holdings Parent, Inc. (NYSE: CON) saw its stock rise by 5.6% following its reclassification into Russell growth-defensive indexes and the opening of a new occupational health clinic in Arizona. This shift, coupled with an "Outperform" rating from William Blair and raised 2026 sales guidance, reinforces Concentra's position as a specialized workplace health provider. The article highlights the importance of execution on expansion, integration, and managing high leverage for sustainable profitability.
Price to earnings forward of Concentra Group Holdings Parent, Inc. – NYSE:CON
This article provides financial information for Concentra Group Holdings Parent, Inc. (NYSE: CON), specifically focusing on its forward price-to-earnings ratio. The content is hosted on TradingView, an investment analysis platform.
William Blair Initiates Concentra Group at Outperform
William Blair has initiated coverage on Concentra Group with an "Outperform" rating. This rating suggests that the firm believes Concentra Group's stock will perform better than the broader market or its industry peers. Investors often monitor new analyst coverage for insights into potential investment opportunities.
William Blair Initiates Concentra Group at Outperform
William Blair has initiated coverage of Concentra Group Holdings Parent, Inc. (NYSE: CON) with an "Outperform" rating. The healthcare company, which provides occupational and consumer health services across 41 states and 44 states for onsite clinics, saw its stock rise by 3.43% today. This initiation follows recent changes in its Russell index inclusions and several analyst target price adjustments.
Enterprise value to EBITDA forward of Concentra Group Holdings Parent, Inc. – NYSE:CON
This article provides financial data for Concentra Group Holdings Parent, Inc. (NYSE: CON), specifically focusing on its enterprise value to forward EBITDA. It indicates key financial metrics and disclaims data sources like ICE Data Services and FactSet, highlighting that TradingView is the platform presenting this information.
Form 144 Concentra Group Holdings Parent For: 30 June By Investing.com
This article announces the filing of Form 144 for Concentra Group Holdings Parent for June 30. It is a brief report from Investing.com, providing basic information without further details within the main text.
CON or MEDP: Which Is the Better Value Stock Right Now?
This article analyzes whether Concentra Group (CON) or Medpace (MEDP) is a better value stock within the Medical Services sector. Using the Zacks Rank and Style Scores, it concludes that CON is the better option due to its stronger Zacks Rank (#2 Buy vs. #3 Hold), more impressive earnings estimate revision activity, and superior value metrics including lower P/E, PEG, and P/B ratios.
Concentra Group Holdings Parent, Inc.(NYSE:CON) dropped from Russell 2000 Value Benchmark
Concentra Group Holdings Parent, Inc. (NYSE:CON) has been removed from the Russell 2000 Value Benchmark, according to a MarketScreener report published on June 29, 2026. This news comes shortly after the company was added to the Russell 2000 Growth-Defensive Index. The article also provides recent news and financial details about Concentra Group Holdings Parent, Inc., including its Q1 2026 earnings and analyst ratings.
Concentra Group Holdings Parent, Inc.(NYSE:CON) dropped from Russell 3000 Value Benchmark
Concentra Group Holdings Parent, Inc. (NYSE:CON) has been removed from the Russell 3000 Value Benchmark. This news comes shortly after the company was added to the Russell 2000 Growth-Defensive Index and Russell 2000 Defensive Index. Concentra Group is a provider of occupational health services in the United States, operating numerous health centers and onsite clinics.
Rocco A Ortenzio Trust proposes two 130,000-share sales (CON)
The Rocco A Ortenzio Trust has filed a Form 144/A indicating proposed sales of Common Stock of CON. The filing outlines two separate proposed sales, each for 130,000 shares, dated May 8, 2026, and June 1, 2026, with corresponding values of $3,250,000.00 and $3,250,026.00 respectively. UBS Financial Services, Inc. is identified as the broker, and the transactions are notifications for compliant disposition under resale rules, not confirmations of completed sales.
CON (NYSE) affiliate reports two 130,000-share dispositions on Form 144
CON, trading on NYSE, filed a Form 144 detailing proposed resales of Common Stock by an affiliate, The Rocco A Ortenzio Trust FBO Robert Ortenzio. The filing indicates two dispositions of 130,000 shares each, one on May 8, 2026, for $3,250,000, and another on June 1, 2026, for $3,250,026. As of June 26, 2026, the company had 127,961,780 shares outstanding.
CON Forecast — Price Target — Prediction for 2027
The article provides a forecast and price target for Concentra Group Holdings Parent, Inc. (CON), an NYSE-traded stock. Eight analysts have given a 1-year price forecast with a maximum estimate of $36.00 and a minimum of $28.00. The stock has shown significant growth over the past year, and analysts suggest a "strong buy" signal based on technical analysis, with the company also paying quarterly dividends.
Concentra Group Holdings Parent, Inc. Actuals & Estimates (NYSE:CON)
This article provides an overview of Concentra Group Holdings Parent, Inc. (NYSE: CON) stock, including current price, historical performance, analyst forecasts, and financial data. It highlights the company's recent stock growth, market capitalization, upcoming earnings date, and details on dividends and financial statements. The article also touches on its volatility, market cap, and offers guidance on how to purchase its stock and conduct research.
Concentra opens 17th Arizona medical center in Goodyear
Concentra has opened its 17th medical center in Arizona, located in Goodyear, to provide occupational health services to various industries. This expansion supports the growing workforce in the West Valley. The company is experiencing strong financial momentum, with impressive Q1 2026 results and several firms raising their price targets, indicating positive analyst sentiment.
Concentra Group Holdings Parent Inc stock hits all-time high at 29.56 USD
Concentra Group Holdings Parent Inc. (CON) stock has reached an all-time high of $29.56, reflecting positive investor sentiment and robust performance. Despite trading above its InvestingPro Fair Value estimate, the company boasts a strong financial health score and has seen a 43.5% total return over the past year. Recent impressive Q1 2026 financial results, including exceeding EPS and revenue expectations, have led analysts to raise price targets, and the company is expanding with a new medical center in Arizona.
Concentra Expands Arizona Presence with New Goodyear Medical Center
Concentra, a leader in occupational and workforce health services, has opened its first medical center in Goodyear, Arizona, marking its 17th location in the state. This new facility will provide comprehensive occupational health services, including injury care, physical therapy, and drug testing, to support the growing industrial workforce in the West Valley. The expansion aims to offer accessible care closer to employees and help employers manage workplace health needs efficiently.
Concentra Group Holdings Parent Inc (CON) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis of Concentra Group Holdings Parent Inc (CON), focusing on its P/E ratio and overall valuation score. The company's valuation score is 8.86, ranking 31st in its industry, with a current P/E ratio of 20.55. The article notes that data for P/B, P/S, and P/CF ratios have not yet been disclosed by the company.
Concentra Group Holdings Parent Inc
This article provides a detailed revenue breakdown for Concentra Group Holdings Parent Inc (CON) by business segment. As of April 6, the company's revenue primarily comes from occupational health centers, with workers' compensation and employer services being the largest contributors. The data shows specific figures and proportions for each segment across various fiscal years and quarters.
Concentra Group Holdings Parent Inc stock hits all-time high at 28.62 USD
Concentra Group Holdings Parent Inc. (CON) has hit an all-time high of $28.64, driven by a 37% 1-year change and a 45% YTD return, backed by a perfect Piotroski Score of 9 and robust financial health. Recent strong Q1 2026 earnings, reporting $0.40 EPS and $569.6 million revenue, led analysts from Mizuho, Truist Securities, and Goldman Sachs to raise price targets and issue Buy/Outperform ratings, highlighting the company's strong position in occupational health.
Concentra Group Holdings Parent Inc (CON) Earnings Forecast: Future EPS & Revenue Growth Estimates
The article provides an earnings forecast for Concentra Group Holdings Parent Inc (CON), noting its current earnings forecast score of 8.29, ranking 21st in the Healthcare Providers & Services industry. Analysts have an average price target of $28.50 for CON, with a "Buy" trend recommendation based on ratings from 8 analysts. The company's expected revenue for the next quarter is $591.72 million, and the EPS forecast for the next quarter is $0.42.
Concentra Group Holdings Parent Inc stock hits all-time high at 28.62 USD
Concentra Group Holdings Parent Inc.'s stock has reached an all-time high of $28.64, driven by a 37% 1-year change and a 45% year-to-date return. The company, which boasts a "GREAT" financial health rating and a perfect Piotroski Score of 9, recently reported strong Q1 2026 earnings, exceeding expectations with $0.40 EPS and $569.6 million in revenue. Analysts from Mizuho, Truist Securities, and Goldman Sachs have responded by raising price targets and initiating buy ratings, underscoring positive operational performance and future prospects.
Concentra Group Holdings stock hits all-time high at 26.69 USD
Concentra Group Holdings Parent Inc. stock has reached an all-time high of $26.69, surging 34% over the past six months and 33% year-to-date. The company is considered undervalued with a strong financial health score and reported impressive Q1 2026 results. Analyst firms have responded by raising price targets and initiating buy ratings, highlighting the company's robust market presence and performance.
Concentra Group Holdings stock hits all-time high at 26.69 USD
Concentra Group Holdings Parent Inc. stock has reached an all-time high of $26.69, surging 34% in the last six months and 33% year-to-date, with a 20% increase over the past year. InvestingPro analysis indicates the stock is undervalued with a "GREAT" financial health score and a perfect Piotroski Score of 9. Recent strong Q1 2026 financial results, including exceeding EPS expectations and a 13.7% revenue increase, have led to raised price targets from several analyst firms.
Concentra Group Holdings stock hits all-time high at 26.69 USD
Concentra Group Holdings stock reached an all-time high of $26.69, having surged 34% in the past six months and 33% year-to-date. InvestingPro analysis indicates the stock is undervalued with a "GREAT" financial health score and a perfect Piotroski Score of 9. Recent strong Q1 2026 financial results, with EPS of $0.40 and revenue of $569.6 million, have led multiple analyst firms to raise price targets, citing robust performance and market position.
55,314 Shares in Concentra Group Holdings Parent, Inc. $CON Bought by Fox Run Management L.L.C.
Fox Run Management L.L.C. recently acquired 55,314 shares of Concentra Group Holdings Parent, Inc. (NYSE:CON) valued at approximately $1.09 million in the fourth quarter. This comes as the company reported strong quarterly results, with EPS of $0.40 and revenue of $569.56 million both exceeding estimates, and revenue growing 13.7% year over year. Analysts maintain a constructive outlook on the stock, with a consensus "Moderate Buy" rating and a price target of $30.20 compared to recent trading near $26.08.
Did Goldman Sachs’ Endorsement of Concentra’s Pricing Power Just Shift Concentra Group Holdings Parent's (CON) Investment Narrative?
Goldman Sachs initiated coverage on Concentra Group Holdings Parent Inc. (CON) with a buy rating, emphasizing its national scale and strong position in the US occupational health market, particularly its durable pricing power. This endorsement, following positive views from Truist Securities and Mizuho, reinforces Concentra's existing investment thesis centered on its ability to support steady visit growth and margins. While the backing strengthens confidence, investors are cautioned about the company's high leverage and interest burden, which could become more significant under certain conditions.
Concentra Group Price Target Announced at $30.00/Share by Goldman Sachs
Goldman Sachs has initiated coverage on Concentra Group, setting a price target of $30.00 per share. This target suggests a potential upside for the company's stock, indicating analyst confidence in its future performance.
Concentra Group Holdings Parent (NYSE:CON) Now Covered by The Goldman Sachs Group
The Goldman Sachs Group has initiated coverage on Concentra Group Holdings Parent (NYSE:CON) with a "buy" rating and a $30.00 price target, suggesting a 20.08% upside. This new coverage aligns with other positive analyst ratings, leading to a consensus "Moderate Buy" rating and an average price target of $30.20. The company recently reported strong quarterly earnings, surpassing EPS and revenue estimates, although a director did sell a significant number of shares through a pre-arranged trading plan.
Goldman Sachs initiates Concentra stock with buy rating on pricing durability By Investing.com
Goldman Sachs initiated coverage on Concentra Group Holdings Parent Inc (NYSE:CON) with a buy rating and a price target of $30.00, citing its leadership in occupational health and consistent growth. The firm highlighted Concentra's national scale, predictable pricing, and capital-efficient growth drivers. Additionally, Concentra recently reported strong Q1 2026 financial results, exceeding expectations for EPS and revenue, leading other firms like Truist Securities and Mizuho to raise their price targets.
CON (NYSE: CON) affiliate Robert Ortenzio proposes sale of 130,000 shares
Robert A. Ortenzio, an affiliate of CON (NYSE: CON), has filed a Form 144 to propose the sale of 130,000 shares of common stock, valued at an aggregate of $3,250,000. These shares were acquired via a private purchase on April 29, 2005, with a listed sale date of May 8, 2026. The filing is a routine regulatory disclosure for an affiliate resale and does not indicate new company operational information.
Trust tied to Concentra (NYSE: CON) director sells 130,000 shares
A trust associated with Robert A. Ortenzio, a director at Concentra Group Holdings Parent, Inc. (NYSE: CON), sold 130,000 shares of common stock on June 1, 2026. The shares were sold in an open-market transaction at a weighted average price of $25.0002 per share, totaling approximately $3.25 million. Following this transaction, the trust retains 763,455 shares, while Ortenzio also holds significant indirect and direct shares through various trusts and personal holdings.
CON Initiates Coverage On Goldman Sachs -- Rating Set to Buy
Goldman Sachs has initiated coverage on Concentra Group Holdings (CON) with a "Buy" rating and a price target of $30.00, suggesting the stock may be undervalued. Despite this positive analyst outlook, Concentra has a low GF Score™ of 21/100, indicating potential weaknesses in growth and valuation, and has seen significant insider selling of $6.5 million in the last three months. Investors are advised to consider both the favorable analyst rating and the company's internal metrics before making investment decisions.
Goldman Sachs initiates Concentra stock with buy rating on pricing durability
Goldman Sachs initiated coverage on Concentra Group Holdings Parent Inc (NYSE:CON) with a buy rating and a price target of $30.00, citing the company's leading position in occupational health, consistent pricing trends, and durable growth profile. The firm highlighted Concentra's strong financial health and capital-efficient growth, predicting a 20% upside from its current trading price. This positive outlook follows Concentra's impressive Q1 2026 results, which led other firms like Truist Securities and Mizuho to raise their price targets.
Concentra Group Holdings Parent, Inc. Bonds — Corporate Bond Rates
This article provides a list of corporate bonds for Concentra Group Holdings Parent, Inc., sorted by yield to worst, including details such as symbol, yield, price, coupon, maturity date, and S&P rating. It highlights that investors often choose corporate bonds for their stability during market volatility. The data helps investors analyze prices, yields, and other statistics to find suitable investment opportunities.
CON - Concentra Group Holdings Parent Inc Stock Price and Quote
This page provides a detailed financial overview and stock quote for Concentra Group Holdings Parent Inc. (CON), including real-time stock performance metrics, key financial ratios, upcoming earnings dates, recent news, and insider trading activities. It highlights the company's business segments, leadership, and analyst ratings, offering a comprehensive snapshot for investors.
Are options traders betting on a big move in Concentra Group stock?
This article from MSN focuses on options trading activities related to Concentra Group stock. It suggests that traders might be anticipating a significant price movement in the company's shares. However, the provided content is minimal and doesn't offer further details.
8-K: Concentra Group Holdings Parent, Inc. Announces Fourth Quarter and Year Ended 2025 Results - moomoo
The document is an 8-K filing by Concentra Group Holdings Parent, Inc. announcing its financial results for the fourth quarter and the full year ended 2025. This type of filing is used to disclose material events or information that shareholders should know about. Investors would typically look at this filing for details on the company's financial performance.
Analysts Offer Insights on Financial Companies: Ehealth (EHTH), Robinhood (HOOD) and Charles Schwab (SCHW)
This article summarizes analyst ratings for Ehealth (EHTH), Robinhood (HOOD), and Charles Schwab (SCHW). RBC Capital maintained a Hold on Ehealth with a $3.00 price target, while Needham's John Todaro gave Robinhood a Buy rating and an $85.00 target. TD Cowen's William Katz maintained a Buy rating on Charles Schwab with a $109.00 price target.
Trust linked to Concentra (NYSE: CON) director sells 130k shares
A trust associated with Concentra Group Holdings Parent, Inc. (NYSE: CON) director Robert A. Ortenzio sold 130,000 shares of common stock at $25.00 per share in an indirect open-market transaction. Following the sale, The Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio holds 893,455 shares. Ortenzio also directly owns 5,533,794 shares and has other indirect holdings through various family trusts.
Read This Before Considering Concentra Group Holdings Parent, Inc. (NYSE:CON) For Its Upcoming US$0.0625 Dividend
Concentra Group Holdings Parent, Inc. (NYSE:CON) is set to pay a US$0.0625 dividend, with the ex-dividend date around May 19th. The company's dividend is well-covered by both profits (18% payout ratio) and free cash flow (19% payout ratio), suggesting sustainability. However, a 7.2% per annum decline in earnings over the past five years raises concerns about the long-term reliability of the dividend, despite flat dividend payments over the last two years.
Read This Before Considering Concentra Group Holdings Parent, Inc. (NYSE:CON) For Its Upcoming US$0.0625 Dividend
Concentra Group Holdings Parent, Inc. (NYSE:CON) is preparing to pay a quarterly dividend of US$0.0625 per share, with an ex-dividend date around May 19th. The company's dividend payout ratios for both profit (18%) and free cash flow (19%) are comfortably low, suggesting sustainability. However, a significant concern is a 7.2% decline in earnings per annum over the past five years, which could challenge the dividend's long-term sustainability despite the current low payout ratios.
RBC Capital Remains a Buy on Concentra Group Holdings Parent, Inc. (CON)
RBC Capital analyst Ben Hendrix maintained a Buy rating for Concentra Group Holdings Parent, Inc. (CON) with a $36.00 price target. This aligns with a "Strong Buy" analyst consensus and a $30.00 average price target, indicating a 20.00% upside. The company recently reported strong quarterly revenues of $569.56 million and a net profit of $50.49 million, though insider sentiment is negative due to increased selling activity.
Concentra group director Robert Ortenzio sells $3.25m in stock
Robert A. Ortenzio, a director at Concentra Group Holdings Parent, Inc. (NASDAQ:CON), sold 130,000 shares of company stock for $3.25 million on May 8, 2026. This sale occurred as the stock reached its 52-week high after a strong 23% year-to-date gain, with InvestingPro suggesting the stock is currently overvalued. Ortenzio maintains substantial direct and indirect holdings in the company through various trusts.
